Idiopathic duct-centric pancreatitis: Disease description and endoscopic ultrasonography-guided trucut biopsy diagnosis

Michael J. Levy, Thomas Christopher Smyrk, Naoki Takahashi, Lizhi Zhang, Suresh T Chari

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Background/Aims: Recent data demonstrate the presence of two autoimmune pancreatitis (AIP) subtypes. All existing endoscopic ultrasonography-guided trucut biopsy (EUS-TCB) data pertain to type 1 disease. Our aim is to determine if EUS-TCB samples are sufficient for diagnosing type 2 AIP. Methods: This is a retrospective case series conducted in an academic tertiary care center. Patients included those with type 2 AIP (n = 5), retrospectively identified from a database of all patients with AIP, diagnosed by HISORt criteria (n = 125). The primary outcome measure was the diagnostic capability of EUS-TCB for type 2 AIP. Results: 5 patients (4 male, 1 female; mean age 39.6 years) who underwent EUS-TCB were diagnosed with type 2 AIP. The serum IgG 4 level was elevated in 1 of the 4 patients tested. CT/MRI revealed diffuse pancreas enlargement (n = 3), a pancreas head mass (n = 1), and a normal pancreas (n = 1). Prior to EUS, AIP was not specifically suspected, but part of a broad differential (n = 3) or not suspected at all (n = 2). Fine-needle aspiration was negative for neoplasia and AIP. The TCB histology was definitive (n = 4) or suggestive (n = 1) for type 2 AIP. No complications developed. Conclusions: EUS-TCB may be safe and may provide sufficient material to definitively diagnose type 2 AIP.

Original languageEnglish (US)
Pages (from-to)76-80
Number of pages5
JournalPancreatology
Volume11
Issue number1
DOIs
StatePublished - Jun 2011

Fingerprint

Endosonography
Pancreatitis
Biopsy
Pancreas
Fine Needle Biopsy
Tertiary Care Centers
Histology
Immunoglobulin G
Outcome Assessment (Health Care)
Databases

Keywords

  • Autoimmune pancreatitis
  • Endoscopic ultrasonography
  • Trucut biopsy

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Hepatology

Cite this

Idiopathic duct-centric pancreatitis : Disease description and endoscopic ultrasonography-guided trucut biopsy diagnosis. / Levy, Michael J.; Smyrk, Thomas Christopher; Takahashi, Naoki; Zhang, Lizhi; Chari, Suresh T.

In: Pancreatology, Vol. 11, No. 1, 06.2011, p. 76-80.

Research output: Contribution to journalArticle

@article{70f532c8553f403aad06ae6590b52ce3,
title = "Idiopathic duct-centric pancreatitis: Disease description and endoscopic ultrasonography-guided trucut biopsy diagnosis",
abstract = "Background/Aims: Recent data demonstrate the presence of two autoimmune pancreatitis (AIP) subtypes. All existing endoscopic ultrasonography-guided trucut biopsy (EUS-TCB) data pertain to type 1 disease. Our aim is to determine if EUS-TCB samples are sufficient for diagnosing type 2 AIP. Methods: This is a retrospective case series conducted in an academic tertiary care center. Patients included those with type 2 AIP (n = 5), retrospectively identified from a database of all patients with AIP, diagnosed by HISORt criteria (n = 125). The primary outcome measure was the diagnostic capability of EUS-TCB for type 2 AIP. Results: 5 patients (4 male, 1 female; mean age 39.6 years) who underwent EUS-TCB were diagnosed with type 2 AIP. The serum IgG 4 level was elevated in 1 of the 4 patients tested. CT/MRI revealed diffuse pancreas enlargement (n = 3), a pancreas head mass (n = 1), and a normal pancreas (n = 1). Prior to EUS, AIP was not specifically suspected, but part of a broad differential (n = 3) or not suspected at all (n = 2). Fine-needle aspiration was negative for neoplasia and AIP. The TCB histology was definitive (n = 4) or suggestive (n = 1) for type 2 AIP. No complications developed. Conclusions: EUS-TCB may be safe and may provide sufficient material to definitively diagnose type 2 AIP.",
keywords = "Autoimmune pancreatitis, Endoscopic ultrasonography, Trucut biopsy",
author = "Levy, {Michael J.} and Smyrk, {Thomas Christopher} and Naoki Takahashi and Lizhi Zhang and Chari, {Suresh T}",
year = "2011",
month = "6",
doi = "10.1159/000324189",
language = "English (US)",
volume = "11",
pages = "76--80",
journal = "Pancreatology",
issn = "1424-3903",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Idiopathic duct-centric pancreatitis

T2 - Disease description and endoscopic ultrasonography-guided trucut biopsy diagnosis

AU - Levy, Michael J.

AU - Smyrk, Thomas Christopher

AU - Takahashi, Naoki

AU - Zhang, Lizhi

AU - Chari, Suresh T

PY - 2011/6

Y1 - 2011/6

N2 - Background/Aims: Recent data demonstrate the presence of two autoimmune pancreatitis (AIP) subtypes. All existing endoscopic ultrasonography-guided trucut biopsy (EUS-TCB) data pertain to type 1 disease. Our aim is to determine if EUS-TCB samples are sufficient for diagnosing type 2 AIP. Methods: This is a retrospective case series conducted in an academic tertiary care center. Patients included those with type 2 AIP (n = 5), retrospectively identified from a database of all patients with AIP, diagnosed by HISORt criteria (n = 125). The primary outcome measure was the diagnostic capability of EUS-TCB for type 2 AIP. Results: 5 patients (4 male, 1 female; mean age 39.6 years) who underwent EUS-TCB were diagnosed with type 2 AIP. The serum IgG 4 level was elevated in 1 of the 4 patients tested. CT/MRI revealed diffuse pancreas enlargement (n = 3), a pancreas head mass (n = 1), and a normal pancreas (n = 1). Prior to EUS, AIP was not specifically suspected, but part of a broad differential (n = 3) or not suspected at all (n = 2). Fine-needle aspiration was negative for neoplasia and AIP. The TCB histology was definitive (n = 4) or suggestive (n = 1) for type 2 AIP. No complications developed. Conclusions: EUS-TCB may be safe and may provide sufficient material to definitively diagnose type 2 AIP.

AB - Background/Aims: Recent data demonstrate the presence of two autoimmune pancreatitis (AIP) subtypes. All existing endoscopic ultrasonography-guided trucut biopsy (EUS-TCB) data pertain to type 1 disease. Our aim is to determine if EUS-TCB samples are sufficient for diagnosing type 2 AIP. Methods: This is a retrospective case series conducted in an academic tertiary care center. Patients included those with type 2 AIP (n = 5), retrospectively identified from a database of all patients with AIP, diagnosed by HISORt criteria (n = 125). The primary outcome measure was the diagnostic capability of EUS-TCB for type 2 AIP. Results: 5 patients (4 male, 1 female; mean age 39.6 years) who underwent EUS-TCB were diagnosed with type 2 AIP. The serum IgG 4 level was elevated in 1 of the 4 patients tested. CT/MRI revealed diffuse pancreas enlargement (n = 3), a pancreas head mass (n = 1), and a normal pancreas (n = 1). Prior to EUS, AIP was not specifically suspected, but part of a broad differential (n = 3) or not suspected at all (n = 2). Fine-needle aspiration was negative for neoplasia and AIP. The TCB histology was definitive (n = 4) or suggestive (n = 1) for type 2 AIP. No complications developed. Conclusions: EUS-TCB may be safe and may provide sufficient material to definitively diagnose type 2 AIP.

KW - Autoimmune pancreatitis

KW - Endoscopic ultrasonography

KW - Trucut biopsy

UR - http://www.scopus.com/inward/record.url?scp=79955115610&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955115610&partnerID=8YFLogxK

U2 - 10.1159/000324189

DO - 10.1159/000324189

M3 - Article

C2 - 21525775

AN - SCOPUS:79955115610

VL - 11

SP - 76

EP - 80

JO - Pancreatology

JF - Pancreatology

SN - 1424-3903

IS - 1

ER -